166 related articles for article (PubMed ID: 11769074)
1. [Endovesical chemotherapy for superficial bladder tumors].
Chopin D; Gattegno B
Prog Urol; 2001 Nov; 11(5):1047-64. PubMed ID: 11769074
[No Abstract] [Full Text] [Related]
2. Is intravesical chemotherapy for superficial bladder cancer still justified?
Okeke AA; Probert JL; Gillatt DA; Schwaibold H
BJU Int; 2005 Oct; 96(6):763-7. PubMed ID: 16153195
[No Abstract] [Full Text] [Related]
3. Objective response of superficial bladder tumors to intravesical treatment (including review of response of marker lesions).
Bouffioux C; van der Meijden A; Kurth KH; Jakse G; Bono A; Hall R; Oosterlinck W; Sylvester R
Prog Clin Biol Res; 1992; 378():29-42. PubMed ID: 1301584
[No Abstract] [Full Text] [Related]
4. When does superficial bladder cancer resist intravesical therapy?
Vögeli T; Ackermann R
Semin Urol; 1990 Nov; 8(4):248-53. PubMed ID: 2284531
[No Abstract] [Full Text] [Related]
5. Intravesical chemoprophylaxis of superficial transitional cell carcinoma of the bladder. When should the drug be given?
Bouffioux C
Prog Clin Biol Res; 1985; 185B():47-55. PubMed ID: 4034591
[No Abstract] [Full Text] [Related]
6. Intracavitary treatment of transitional cell carcinoma of the bladder: questions and lessons after 27 years of experience.
Kurth KH; Sylvester R; de Pauw M; ten Kate F
Prog Clin Biol Res; 1989; 310():125-45. PubMed ID: 2672012
[No Abstract] [Full Text] [Related]
7. Editorial comment on: Long-term intravesical adjuvant chemotherapy further reduces recurrence rate compared with short-term intravesical chemotherapy and short-term therapy with Bacillus Calmette-Guérin (BCG) in patients with non-muscle-invasive bladder cancer.
Evans CP
Eur Urol; 2007 Oct; 52(4):1129-30. PubMed ID: 17383082
[No Abstract] [Full Text] [Related]
8. [Treatment of superficial transitional cell carcinoma of the bladder].
Nissenkorn J
Harefuah; 1982 May; 102(10):436-8. PubMed ID: 7160676
[No Abstract] [Full Text] [Related]
9. [Postoperative and adjuvant intravesical therapy of superficial bladder tumours. Clinical practice and applied therapeutic agents].
Lingnau A; Miller K; Steiner U; Jentzmik F; Weikert S; Schostak M
Aktuelle Urol; 2009 Sep; 40(5):307-9. PubMed ID: 19637135
[TBL] [Abstract][Full Text] [Related]
10. Risk-adapted use of intravesical chemotherapy.
Lerner SP; Au JL
BJU Int; 2008 Nov; 102(9 Pt B):1247-53. PubMed ID: 19035889
[No Abstract] [Full Text] [Related]
11. Complications of intravesical therapy for urothelial cancer of the bladder.
Koya MP; Simon MA; Soloway MS
J Urol; 2006 Jun; 175(6):2004-10. PubMed ID: 16697786
[TBL] [Abstract][Full Text] [Related]
12. [Endovesical immunotherapy: Calmette-Guérin bacillus].
Chopin D; Saint F; Gattegno B
Prog Urol; 2001 Nov; 11(5):1067-115. PubMed ID: 11769075
[No Abstract] [Full Text] [Related]
13. Intravesical mitomycin C for superficial transitional cell carcinoma.
Bolenz C; Cao Y; Arancibia MF; Trojan L; Alken P; Michel MS
Expert Rev Anticancer Ther; 2006 Aug; 6(8):1273-82. PubMed ID: 16925493
[TBL] [Abstract][Full Text] [Related]
14. Impact of intravesical chemotherapy versus BCG immunotherapy on recurrence of superficial transitional cell carcinoma of the bladder: metaanalytic reevaluation.
Huncharek M; Kupelnick B
Am J Clin Oncol; 2003 Aug; 26(4):402-7. PubMed ID: 12902895
[TBL] [Abstract][Full Text] [Related]
15. [Bladder wall permeability to to topically administered cisplatin].
Zyrianov BN; Selivanov SP
Urologiia; 2000; (5):28-30. PubMed ID: 11392221
[TBL] [Abstract][Full Text] [Related]
16. When should we stop intravesical treatment in patients with superficial bladder cancer?
von Heyden B; Jakse G
Recent Results Cancer Res; 1993; 126():127-33. PubMed ID: 8456183
[No Abstract] [Full Text] [Related]
17. Transferrin-conjugated liposome targeting of photosensitizer AlPcS4 to rat bladder carcinoma cells.
Derycke AS; Kamuhabwa A; Gijsens A; Roskams T; De Vos D; Kasran A; Huwyler J; Missiaen L; de Witte PA
J Natl Cancer Inst; 2004 Nov; 96(21):1620-30. PubMed ID: 15523091
[TBL] [Abstract][Full Text] [Related]
18. [Conservative treatment of superficial transitional cell carcinoma of the bladder].
Gruenwald I; Stein A; Lurie A
Harefuah; 1995 Jan; 128(2):104-11. PubMed ID: 7721171
[No Abstract] [Full Text] [Related]
19. [Superficial bladder cancer with lung metastasis without local invasion: a case report].
Hirayama T; Matsumoto K; Irie A; Iwamura M; Kudoh O; Iwabuchi K; Ao T; Uchida T; Baba S
Hinyokika Kiyo; 2007 Mar; 53(3):179-82. PubMed ID: 17447488
[TBL] [Abstract][Full Text] [Related]
20. Phase I/II pilot study of intravesical apaziquone (EO9) for superficial bladder cancer.
Puri R; Palit V; Loadman PM; Flannigan M; Shah T; Choudry GA; Basu S; Double JA; Lenaz G; Chawla S; Beer M; Van Kalken C; de Boer R; Beijnen JH; Twelves CJ; Phillips RM
J Urol; 2006 Oct; 176(4 Pt 1):1344-8. PubMed ID: 16952628
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
